Regular AREDS2 Supplement Use in Age-Related Macular Degeneration: Factors Associated with Supplementation, Medication Adherence, and Patient-Reported Barriers.

Öncül H, Dağ U, Alakuş MF

Open source

DOI
10.3390/healthcare14172733
Published
2026 Aug 27
Container
Healthcare (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/healthcare14172733,
  title = {Regular AREDS2 Supplement Use in Age-Related Macular Degeneration: Factors Associated with Supplementation, Medication Adherence, and Patient-Reported Barriers.},
  author = {Öncül H and Dağ U and Alakuş MF},
  year = {2026},
  journal = {Healthcare (Basel, Switzerland)},
  doi = {10.3390/healthcare14172733},
  url = {https://doi.org/10.3390/healthcare14172733}
}

RIS

TY  - JOUR
TI  - Regular AREDS2 Supplement Use in Age-Related Macular Degeneration: Factors Associated with Supplementation, Medication Adherence, and Patient-Reported Barriers.
AU  - Öncül H
AU  - Dağ U
AU  - Alakuş MF
PY  - 2026
JO  - Healthcare (Basel, Switzerland)
DO  - 10.3390/healthcare14172733
UR  - https://doi.org/10.3390/healthcare14172733
ER  - 

APA

H, Ö., U, D., & MF, A. (2026). Regular AREDS2 Supplement Use in Age-Related Macular Degeneration: Factors Associated with Supplementation, Medication Adherence, and Patient-Reported Barriers.. Healthcare (Basel, Switzerland). https://doi.org/10.3390/healthcare14172733

Source records